Annual Cash & Cash Equivalents
$12.61 M
+$505.10 K+4.17%
June 30, 2024
Summary
- As of February 8, 2025, BNOX annual cash & cash equivalents is $12.61 million, with the most recent change of +$505.10 thousand (+4.17%) on June 30, 2024.
- During the last 3 years, BNOX annual cash & cash equivalents has fallen by -$8.80 million (-41.12%).
- BNOX annual cash & cash equivalents is now -62.85% below its all-time high of $33.94 million, reached on June 30, 2016.
Performance
BNOX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.08 M
-$4.53 M-35.90%
September 30, 2024
Summary
- As of February 8, 2025, BNOX quarterly cash and cash equivalents is $8.08 million, with the most recent change of -$4.53 million (-35.90%) on September 30, 2024.
- Over the past year, BNOX quarterly cash and cash equivalents has dropped by -$4.53 million (-35.90%).
- BNOX quarterly cash and cash equivalents is now -78.41% below its all-time high of $37.43 million, reached on December 1, 2015.
Performance
BNOX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BNOX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.2% | -35.9% |
| 3 y3 years | -41.1% | -61.3% |
| 5 y5 years | +28.7% | +83.2% |
BNOX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.4% | +4.2% | -72.4% | at low |
| 5 y | 5-year | -45.4% | +300.8% | -72.4% | +156.9% |
| alltime | all time | -62.9% | >+9999.0% | -78.4% | >+9999.0% |
Bionomics Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.08 M(-35.9%) |
| Jun 2024 | $12.61 M(+4.2%) | $12.61 M(+24.5%) |
| Dec 2023 | - | $10.13 M(-16.3%) |
| Jun 2023 | $12.10 M(-47.6%) | $12.10 M(-42.0%) |
| Dec 2022 | - | $20.88 M(-9.6%) |
| Jun 2022 | $23.09 M(+7.8%) | $23.09 M(-21.1%) |
| Dec 2021 | - | $29.25 M(+36.6%) |
| Jun 2021 | $21.41 M(+580.7%) | $21.41 M(+385.2%) |
| Dec 2020 | - | $4.41 M(+40.3%) |
| Jun 2020 | $3.15 M(-67.9%) | $3.15 M(-47.8%) |
| Dec 2019 | - | $6.03 M(-38.5%) |
| Jun 2019 | $9.79 M(-46.5%) | $9.79 M(-49.2%) |
| Dec 2018 | - | $19.27 M(+5.2%) |
| Jun 2018 | $18.31 M(-44.4%) | $18.31 M(-26.7%) |
| Dec 2017 | - | $24.98 M(-24.2%) |
| Jun 2017 | $32.95 M(-2.9%) | $32.95 M(+6.1%) |
| Dec 2016 | - | $31.06 M(-8.5%) |
| Jun 2016 | $33.94 M(+66.6%) | $33.94 M(-9.3%) |
| Dec 2015 | - | $37.43 M(+83.8%) |
| Jun 2015 | $20.37 M(+106.0%) | $20.37 M(-35.1%) |
| Dec 2014 | - | $31.39 M(+217.5%) |
| Jun 2014 | $9.89 M(-51.8%) | $9.89 M(-45.9%) |
| Dec 2013 | - | $18.26 M(-10.9%) |
| Jun 2013 | $20.49 M(+15.5%) | $20.49 M(+112.3%) |
| Dec 2012 | - | $9.65 M(-45.6%) |
| Jun 2012 | $17.74 M | $17.74 M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $18.28 M(+6.6%) |
| Jun 2011 | $17.16 M(+60.1%) | $17.16 M(+99.3%) |
| Dec 2010 | - | $8.61 M(-19.7%) |
| Jun 2010 | $10.72 M(+179.2%) | $10.72 M(-25.6%) |
| Dec 2009 | - | $14.40 M(+275.1%) |
| Jun 2009 | $3.84 M(-36.1%) | $3.84 M(+26.8%) |
| Dec 2008 | - | $3.03 M(-49.6%) |
| Jun 2008 | $6.01 M(-44.7%) | $6.01 M(-22.9%) |
| Dec 2007 | - | $7.79 M(-28.3%) |
| Jun 2007 | $10.87 M(+209.9%) | $10.87 M(+96.8%) |
| Dec 2006 | - | $5.52 M(+57.5%) |
| Jun 2006 | $3.51 M(-48.9%) | $3.51 M(-25.0%) |
| Dec 2005 | - | $4.68 M(-31.9%) |
| Jun 2005 | $6.87 M(+12.8%) | $6.87 M(+18.2%) |
| Dec 2004 | - | $5.81 M(-4.6%) |
| Jun 2004 | $6.08 M(+48.8%) | $6.08 M(+63.1%) |
| Dec 2003 | - | $3.73 M(-8.8%) |
| Jun 2003 | $4.09 M(-15.4%) | $4.09 M(+8.5%) |
| Dec 2002 | - | $3.77 M(-22.1%) |
| Jun 2002 | $4.84 M(>+9900.0%) | - |
| Jun 2002 | - | $4.84 M(-4.3%) |
| Dec 2001 | - | $5.06 M(>+9900.0%) |
| Jun 2001 | $700.00(-99.8%) | - |
| Jun 2001 | - | $700.00(-100.0%) |
| Dec 2000 | - | $4.35 M |
| Jun 2000 | $312.10 K(+443.7%) | - |
| Jun 1999 | $57.40 K | - |
FAQ
- What is Bionomics Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bionomics Limited?
- What is Bionomics Limited annual cash & cash equivalents year-on-year change?
- What is Bionomics Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bionomics Limited?
- What is Bionomics Limited quarterly cash and cash equivalents year-on-year change?
What is Bionomics Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of BNOX is $12.61 M
What is the all time high annual cash & cash equivalents for Bionomics Limited?
Bionomics Limited all-time high annual cash & cash equivalents is $33.94 M
What is Bionomics Limited annual cash & cash equivalents year-on-year change?
Over the past year, BNOX annual cash & cash equivalents has changed by +$505.10 K (+4.17%)
What is Bionomics Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BNOX is $8.08 M
What is the all time high quarterly cash and cash equivalents for Bionomics Limited?
Bionomics Limited all-time high quarterly cash and cash equivalents is $37.43 M
What is Bionomics Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, BNOX quarterly cash and cash equivalents has changed by -$4.53 M (-35.90%)